Medical News

RSS

Nearly half of employers may stop employee’s health benefits

A latest speculation suggests that nearly a third of employers are likely to stop offering health insurance to employees in 2014 when major federal healthcare-reform provisions kick in. This comes from a new report by McKinsey Quarterly.

8 Jun 2011

Food poisoning with E coli low but Salmonella high

According to public health officials this Tuesday, progress has been made in combating the microbes behind 50 million yearly U.S. food poisoning cases. These affect one in six Americans. This comes from the newest federal FoodNet report from the Centers for Disease Control and Prevention that shows that total food-borne illnesses dropped by nearly a quarter in the last decade and a half, but salmonella infections have steadily refused to drop, climbing slightly in recent years.

8 Jun 2011

UC Davis and BGI partner to conduct large-scale genome sequencing and functional genomics programs

The University of California, Davis, and BGI, the world's largest genome sequencing institute, agreed today (June 8) to form a partnership to conduct large-scale genome sequencing and functional genomics programs, focusing initially on the areas of food security; human and animal health and wellness; and biodiversity and environmental health.

8 Jun 2011

Survey reveals differences in weight-related counseling among medical specialties

Fewer than half of primary care physicians for adults talk to their patients about diet, exercise and weight management consistently, while pediatricians are somewhat more likely to do so, according to two new studies.

8 Jun 2011

Sandbox announces business accelerator for healthcare industry

Sandbox Industries, a venture capital firm and leading incubator for startup companies, announces Healthbox, one of the first business accelerators in the country to focus exclusively on the healthcare industry. Healthbox builds on the success of Excelerate Labs, the tech accelerator that Sandbox co-founded last year, which Tech Cocktail recently named Top 3 among startup accelerators nationwide.

8 Jun 2011

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.

8 Jun 2011

Therapeutic equivalent to replace penicillin

Antibiotics are among the greatest achievements of medical science. But lately the former multi-purpose weapon fails in the battle against infectious diseases. Bacteria are increasingly developing resistance to antibiotics. Researchers have now found a therapeutic equivalent which could replace penicillin and related phamaceuticals.

8 Jun 2011

Single molecule telomerase activator could extend human cell life indefinitely

When expressed (turned on), the gene (hTERT) located on Chromosome number 5p15.33 activates the enzyme telomerase. Human cells can keep living and dividing indefinitely when telomerase is continually present; i.e. the cells become immortal. Telomerase Activation Sciences, Inc. (T.A. Sciences®) announces TA-65® can extend human cell life indefinitely. TA-65® is a single molecule telomerase activator that turns on the Immortality Gene under controlled laboratory conditions.

8 Jun 2011

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.

8 Jun 2011

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.

8 Jun 2011

First Edition: June 8, 2011

Health insurer Blue Shield of California, under fire for a series of recent rate hikes and the pay of its chief executive, plans to cut this year's premiums by 2.5% for many of its 3.3 million policyholders as part of a new initiative to hold down costs (Helfand, 6/8).

8 Jun 2011

New journal on multiple sclerosis and related disorders

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Multiple Sclerosis and Related Disorders with its first issue publication in January 2012.

8 Jun 2011

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America.

8 Jun 2011

ICU patients should wait a week before receiving intravenous feeding: New study

Patients in the intensive care unit who do not tolerate adequate nutrition from tube feeding should wait a week before receiving intravenous (IV) feeding because, compared with early IV feeding, it enhances recovery from critical illness.

8 Jun 2011

Grifols officially merges with Talecris Biotherapeutics

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1.

8 Jun 2011

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.

8 Jun 2011

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., has been named NOVAPLUS Pharmacy Manufacturer of the Year by Novation, the industry's leading supply contracting company.

8 Jun 2011

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.

8 Jun 2011

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

Covidien, a leading global provider of healthcare products, today announced that a subsidiary of the Company filed an answer and counterclaims against Applied Medical Resources Corporation for patent misuse, non-infringement and invalidity.

8 Jun 2011

Amedisys acquires Beacon Hospice

Amedisys, Inc., one of America's leading home health and hospice companies, today announced that on June 7, 2011, it closed the acquisition of Beacon Hospice, Inc.

8 Jun 2011

Medical News

Nearly half of employers may stop employee’s health benefits

Food poisoning with E coli low but Salmonella high

UC Davis and BGI partner to conduct large-scale genome sequencing and functional genomics programs

Survey reveals differences in weight-related counseling among medical specialties

Sandbox announces business accelerator for healthcare industry

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Therapeutic equivalent to replace penicillin

Single molecule telomerase activator could extend human cell life indefinitely

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

First Edition: June 8, 2011

New journal on multiple sclerosis and related disorders

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

ICU patients should wait a week before receiving intravenous feeding: New study

Grifols officially merges with Talecris Biotherapeutics

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

Amedisys acquires Beacon Hospice

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News